Medanta | Business Upturn

Medanta to invest Rs 550 crore in new 400-bed hospital in Varanasi

Arunika Jain — Wed, 25 Mar 2026 10:20:59 +0000

Global Health Limited, operating under the brand Medanta, has announced plans to establish a 400-bed multi-specialty hospital in Varanasi, Uttar Pradesh. The decision was made during a board meeting held on March 25, 2026, where the directors approved a definitive agreement with Shripal Hospitality LLP and others for a build-to-suit development and lease arrangement. This strategic expansion aims to enhance Medanta’s presence in Uttar Pradesh, which already includes facilities in Lucknow and Noida.

The new hospital will be developed on a strategically located freehold land parcel in the heart of Varanasi, catering to a population base of over 4 million in the city and surrounding regions. Medanta will invest approximately ₹550 crore in the project, focusing on interior services, fit-outs, and medical equipment, while the civil infrastructure will be developed by the partner in accordance with Medanta’s specifications.

Dr. Naresh Trehan, Chairman and Managing Director of Medanta, expressed his enthusiasm for the project, highlighting the cultural and spiritual significance of Varanasi. He emphasised Medanta’s commitment to providing advanced healthcare in densely populated regions, aligning with the organisation’s philosophy of delivering high-quality, patient-centric care.

The proposed hospital will address the growing demand for tertiary care in Varanasi and serve as a key healthcare hub for Eastern Uttar Pradesh. This expansion is expected to strengthen Medanta’s market positioning in the state, building on the foundation established by its existing hospitals.

Pankaj Sahni, Group CEO of Medanta, noted the strategic importance of this expansion, acknowledging Varanasi as an underserved market for quality healthcare. He pointed out that the city currently lacks access to high-quality tertiary care, with many existing facilities operating on a smaller scale. The new hospital aims to fill this gap by bringing best-in-class clinical expertise and comprehensive care closer to the local population.

Upon completion, the Varanasi hospital will contribute to Medanta’s goal of becoming one of the largest private hospital networks in Uttar Pradesh, with a total capacity of approximately 1,900 beds.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Medanta expands NCR presence with the launch of a new 550-bed super speciality hospital in Noida

Aman Shukla — Thu, 27 Nov 2025 10:50:32 +0000

Medanta has taken a major step forward in strengthening advanced healthcare access in North India with the inauguration of its new 550-bed super speciality hospital in Noida. The facility, which officially opened on November 27, 2025, was inaugurated by the Chief Minister of Uttar Pradesh, Yogi Adityanath. During the ceremony, he praised Medanta for bringing world-class medical infrastructure and expertise closer to the people of Noida and the wider Western Uttar Pradesh region.

Located in Sector 50, Noida, the new Medanta hospital enjoys seamless connectivity through the Metro network, making it easier for patients across Delhi-NCR to reach the centre. With comprehensive tertiary and quaternary care services spanning more than 25 super specialities—including Cardiology, Oncology, Neurosciences, Gastroenterology, Orthopaedics and many others—the hospital is designed to serve as a critical healthcare hub for the region. The facility includes over 130 ICU beds, 16 advanced operating theatres, and a team of more than 200 highly qualified doctors who have already joined the institution. In addition to enhancing medical access, the hospital is expected to generate between 5,000 and 7,000 employment opportunities, contributing significantly to the state’s healthcare economy.

Medanta Noida stands out for its integration of some of the most advanced medical technologies available today. Among the highlights are the Da Vinci XI Robotic Surgery System, designed to perform minimally invasive procedures with remarkable precision; the Artis Icono Biplane Cath Lab, which offers high-definition 3D imaging for neurovascular and cardiac interventions such as TAVR; and the Varian Edge TruBeam Radiosurgery platform for cutting-edge cancer treatment. The hospital also features an O-Arm Imaging System for real-time surgical imaging and world-class diagnostic tools including a 3 Tesla MRI, a 256-Slice Dual Source CT Scanner, PET Scan, and Gamma Camera.

Medanta receives offer from Assam govt to set up super speciality hospital in Guwahati

Aditya Bhagchandani — Mon, 07 Apr 2025 11:46:12 +0000

Global Health Limited, which operates under the brand name Medanta, has announced that it has received a formal offer from Assam Electricity Grid Corporation Limited (AEGCL), a government entity, for a 3-acre land parcel in Guwahati, Assam. The land has been earmarked for the development of a super speciality hospital, the company disclosed in a regulatory filing dated April 7, 2025.

The proposal, extended by AEGCL, marks a strategic opportunity for Medanta to expand its presence in Northeast India. The management of Global Health Limited stated that it is currently evaluating the offer and working on the next steps.

“We shall keep the exchanges and investors updated on any material development in this regard,” the company added.

The development, once finalized, could significantly boost advanced healthcare access in Assam and the surrounding regions, aligning with Medanta’s expansion and regional outreach goals.

Disclaimer: The information provided is for informational purposes only and subject to updates based on future regulatory filings or company statements.

Medanta Q3 FY25 results: Revenue up 12.8% YoY to Rs 9,434 crore, net profit rises 15.6% YoY

Matrika Shukla — Tue, 04 Feb 2025 11:12:06 +0000

Global Health Limited (Medanta), one of India’s leading multi-specialty hospital chains, has reported a strong financial performance for the quarter ended December 31, 2024 (Q3 FY25), with 12.8% year-on-year (YoY) growth in revenue from operations.

Key financial highlights (Q3 FY25 vs. Q3 FY24)

Revenue from operations: ₹943.4 crore, up 12.8% from ₹836.5 crore in Q3 FY24.
Total income: ₹959.5 crore, an increase from ₹854.5 crore in the same quarter last year.
EBITDA: ₹253.8 crore, compared to ₹238.0 crore in Q3 FY24.
Profit after tax (PAT): ₹142.9 crore, up 15.6% from ₹123.5 crore in Q3 FY24.
EBITDA margin: 26.9%, showing stable operational efficiency.
Earnings per share (EPS): ₹5.32, compared to ₹4.61 in Q3 FY24.

Nine-month performance (April–December 2024 vs. April–December 2023)

Revenue from operations: ₹2,761.1 crore, up 11.9% from ₹2,466.5 crore in the same period last year.
Profit after tax (PAT): ₹379.9 crore, reflecting a 8.3% YoY increase.
Total comprehensive income: ₹381.5 crore, up from ₹349.8 crore last year.

Medanta continues to expand its presence in key markets, with the company adding a 110-bed super-specialty hospital in Ranchi under a lease agreement. The new facility will enhance high-end tertiary and quaternary care services and strengthen Medanta’s presence in Eastern India.

Additionally, Medanta has signed a definitive agreement to operate and manage a 750-bed hospital in Pitampura, New Delhi, further strengthening its position in North India.

With a focus on expansion, operational efficiency, and high-end specialty care, Medanta remains committed to scaling its operations while maintaining profitability. The company’s EBITDA margins and revenue growth trajectory indicate sustained demand for quality healthcare services across India.

Medanta to expand presence in Ranchi with new 110-bed hospital under lease agreement

Matrika Shukla — Tue, 04 Feb 2025 11:06:47 +0000

Global Health Limited (Medanta), one of India’s leading healthcare providers, has announced plans to expand its footprint in Ranchi by adding a newly built 110-bed hospital under a lease agreement with SAC Hospital Management and Consultancy Service Private Limited. The new facility is expected to be operational within six months, subject to necessary regulatory approvals.

Capacity expansion and investment details

Medanta currently operates with a total capacity of over 3,000 beds, with a consolidated capacity utilization of 64% for Q3 FY25. The upcoming hospital, strategically located just 1.2 km from Medanta Ranchi, is expected to enhance tertiary and quaternary care services in the region.

The company will invest up to ₹50 crore in medical and other equipment for the facility, which will be funded through internal accruals. The new hospital will focus on high-end specialty care, filling a critical gap in Ranchi’s healthcare infrastructure.

Lease agreement

Under the lease agreement, SAC Hospital Management and Consultancy Service Private Limited will provide the land and hospital building, while Medanta will handle the investment, operations, and management. The lease will be for an initial period of 15 years, with an option for two extensions of 15 years each, at Medanta’s discretion.

The arrangement is a non-related party transaction, ensuring transparency and compliance with regulatory norms. The lease terms grant Medanta full control over the hospital’s day-to-day operations, allowing for seamless integration with its existing Ranchi facility.

With this expansion, Medanta aims to strengthen its presence in the Eastern region of India while offering advanced medical care. The new facility will focus on high-end tertiary care services, addressing an unmet demand in the area.

Global Health (Medanta) shares rise over 2% as Medanta announces new 750-bed hospital in New Delhi

Aditya Bhagchandani — Thu, 07 Nov 2024 04:27:44 +0000

As of 9:55 am, Global Health Limited (Medanta) shares were trading 1.96% higher at ₹1,095.15 on the NSE, following the announcement of a new 750-bed super-speciality hospital in New Delhi. This expansion is a major step for Medanta as it seeks to enhance healthcare infrastructure in India by providing specialized medical care across disciplines like cardiology, neurology, oncology, and orthopedics.

Medanta has allocated around ₹600 crore to support this venture, with plans to invest over the next three to four years in building state-of-the-art infrastructure and acquiring advanced medical technology. The project aligns with Medanta’s reputation for quality care and is expected to establish a facility that will serve a significant patient base in Delhi and surrounding regions.

Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, emphasized that this facility aims to make high-quality healthcare more accessible. This initiative represents an important milestone in Medanta’s journey to expand its reach and bring comprehensive healthcare services closer to communities.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.

HSBC initiates ‘Reduce’ rating on Global Health (Medanta), sets target price at ₹990

News Desk — Fri, 13 Sep 2024 03:12:52 +0000

HSBC has issued a “Reduce” rating on Global Health (Medanta), with a target price of ₹990. The bank acknowledges Medanta’s ongoing efforts to boost growth through investments in new hospital beds, recruitment of doctors, and expansion of clinical specialties.

However, HSBC warns that the current stock price may not fully reflect the challenges the company faces in its key Lucknow market, along with execution risks tied to its new hospital projects. A potential upside to this outlook could come from stronger-than-expected performance at Medanta’s Lucknow facility.

Global Health (Medanta) shares surge over 5% in morning trade

News Desk — Mon, 02 Sep 2024 05:12:00 +0000

Global Health Limited, operating under the brand name Medanta, is witnessing a significant uptick in its stock price during early trading hours today.

Key highlights:

Current Trading:
- Stock Price: ₹1,192.25
- Gain: ₹57.55 or 5.07%
- Time: 10:39 AM
Today’s Trading Range:
- Open: ₹1,146.30
- High: ₹1,198.00
- Low: ₹1,145.05
Previous Close: ₹1,134.70

The stock has shown strong momentum, opening higher than its previous close and continuing to climb throughout the morning session. It has already touched an intraday high of ₹1,198.00, representing a significant jump from its opening price.

This surge in Medanta’s stock price comes amid broader positive sentiment in the healthcare sector. Investors appear to be bullish on the company’s prospects, though the specific catalyst for today’s movement is not immediately clear.

Market analysts will be closely watching Medanta’s performance throughout the day to see if this upward trend continues and to identify any underlying factors driving this notable price increase.

Veeda Clinical Research gets green signal from SEBI for ₹833 crore IPO

News Desk — Mon, 27 Dec 2021 13:43:42 +0000

Gurgaon based Global Health Ltd. which operates and manages hospitals under its flagship Medanta brand and Clinical research organisation Veeda Clinical Research has managed to receive market regulator SEBI’s green signal to raise funds through an initial public offering (IPO).

The companies have filed their preliminary papers with SEBI in September this year and obtained the observations of the market regulator on December 21, an update with the regulator showed on Monday. In a letter, SEBI expressed, “With the issuance of the observations earlier hereby gives the go-ahead for the IPO.”

According to the draft papers of Global Health’s IPO consists of a fresh issue of equity shares worth Rs 500 crore and an offer for sale (OFS) of up to 4.84 equity shares. As part of the offer for sale, Anant Investments an affiliate company of US-based Carlyle Group will sell up to 4.33 crore equity shares and Global Health’s co-founder Sunil Sachdeva and his wife Suman Sachdeva will sell up to 51 lakh equity shares.

The company intends to utilise the net proceeds from the issue will be used for debt repayment and general corporate purposes. Veeda Clinical Research which offers clinical, preclinical and analytical services to support generic drug manufacturers files its preliminary papers with SEBI to raise Rs 831-crore through an initial public offering.

The Company will issue fresh equity shares worth up to Rs 331.60 crore and an OFS of Rs 500 crore by promoters and its existing stakeholders. Its existing investors are also participating in OFS include CX Alternative Investment, Arabelle Financial Services, Bondway Investment, Stevey International Corporation and Basil Private Limited.

The company will use the net proceeds from the issue for debt repayment, funding its capital expenditure, acquisition of its subsidiary Bioneeds India, funding working capital requirements and general corporate purposes.

DIAL signs MoU with Medanta to set up Covid care centre for Delhi airport employees

News Desk — Mon, 23 Aug 2021 10:40:09 +0000

The Delhi International Airport Limited (DIAL) has signed a memorandum of understanding (MoU) with Medanta hospital to set up a COVID-19 care centre at the Delhi airport for its employees and their family members, a statement said on Monday.

The Covid Care Centre, which is being established at Terminal 2 of the airport in anticipation of “the third wave of the COVID-19 pandemic”, is expected to be operational in early September, said the statement of GMR-group led DIAL. This Centre will help isolate, clinically treat, clinically support asymptomatic, mild and mild to moderate Covid-positive employees of GMR or their family members, till they are transferred to a hospital or discharged to their homes, it mentioned.

“A total of 15 paediatric high dependency unit (HDU) beds, 18 adult HDU beds and 52 isolation beds have been allotted at this centre. Besides, 85 oxygen concentrators have been arranged here,” it noted. This medical support facility will be managed by DIAL under the medical supervision of Medanta hospital, it stated.